A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: TVAX-008
- DRUG: Placebo
Sponsor
Grand Theravac Life Sciences (Nanjing) Co., Ltd.
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]